AGPAT2 anticorps (AA 199-278)

N° du produit ABIN6136640

Détail du produit anti-AGPAT2 anticorps

Antigène: AGPAT2 (1-Acylglycerol-3-Phosphate O-Acyltransferase 2 (Lysophosphatidic Acid Acyltransferase, Beta) (AGPAT2))

Épitope: AA 199-278

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp AGPAT2 est non-conjugé

Application: Western Blotting (WB), Immunofluorescence (IF)

Séquence: IVPVVYSSFS SFYNTKKKFF TSGTVTVQVL EAIPTSGLTA ADVPALVDTC HRAMRTTFLH ISKTPQENGA TAGSGVQPAQ

Réactivité croisée: Humain, Souris

Attributs du produit: Polyclonal Antibodies

Purification: Affinity purification

Immunogène: Recombinant fusion protein containing a sequence corresponding to amino acids 199-278 of human AGPAT2 (NP_006403.2).

Isotype: IgG

Information d'application

Indications d'application: WB,1:500 - 1:2000,IF,1:50 - 1:100

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: PBS with 0.02 % sodium azide,50 % glycerol, pH 7.3.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C

Stockage commentaire: Store at -20°C. Avoid freeze / thaw cycles.

Détails sur AGPAT2

Antigène: AGPAT2 (1-Acylglycerol-3-Phosphate O-Acyltransferase 2 (Lysophosphatidic Acid Acyltransferase, Beta) (AGPAT2))

Autre désignation: AGPAT2 (AGPAT2 Produits)

Synonymes: anticorps AGPAT2, anticorps zgc:153984, anticorps 1-agpat2, anticorps bscl, anticorps bscl1, anticorps lpaab, anticorps lpaat-beta, anticorps 1-AGPAT2, anticorps BSCL, anticorps BSCL1, anticorps LPAAB, anticorps LPAAT-beta, anticorps 2510002J07Rik, anticorps AV000834, anticorps 1-acylglycerol-3-phosphate O-acyltransferase 2, anticorps 1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta), anticorps AGPAT2, anticorps agpat2, anticorps Agpat2

Sujet: This gene encodes a member of the 1-acylglycerol-3-phosphate O-acyltransferase family. The protein is located within the endoplasmic reticulum membrane and converts lysophosphatidic acid to phosphatidic acid, the second step in de novo phospholipid biosynthesis. Mutations in this gene have been associated with congenital generalized lipodystrophy (CGL), or Berardinelli-Seip syndrome, a disease characterized by a near absence of adipose tissue and severe insulin resistance. Alternate transcriptional splice variants, encoding different isoforms, have been characterized.,AGPAT2,1-AGPAT2,BSCL,BSCL1,LPAAB,LPAAT-beta,Cancer,Endocrine & Metabolism,Lipid Metabolism,Cardiovascular,Lipids,Fatty Acids,AGPAT2

Poids moléculaire: 27 kDa/30 kDa

ID gène: 10555

UniProt: O15120